269 related articles for article (PubMed ID: 18245811)
21. Anti-inflammatory effect of electroacupuncture in the C3H/HeJ mouse model of alopecia areata.
Maeda T; Taniguchi M; Matsuzaki S; Shingaki K; Kanazawa S; Miyata S
Acupunct Med; 2013 Mar; 31(1):117-9. PubMed ID: 23103957
[No Abstract] [Full Text] [Related]
22. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
Gilhar A; Kalish RS
Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
[TBL] [Abstract][Full Text] [Related]
23. Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.
Gilhar A; Schrum AG; Etzioni A; Waldmann H; Paus R
Autoimmun Rev; 2016 Jul; 15(7):726-35. PubMed ID: 26971464
[TBL] [Abstract][Full Text] [Related]
24. The antiinflammatory effects of Xuefu Zhuyu decoction on C3H/HeJ mice with alopecia areata.
He X; Duan X; Liu J; Sha X; Gong Y; Lu W; Li Z; Chen X; Li Y; Shen Z
Phytomedicine; 2021 Jan; 81():153423. PubMed ID: 33310308
[TBL] [Abstract][Full Text] [Related]
25. A mouse model of clonal CD8+ T lymphocyte-mediated alopecia areata progressing to alopecia universalis.
Alli R; Nguyen P; Boyd K; Sundberg JP; Geiger TL
J Immunol; 2012 Jan; 188(1):477-86. PubMed ID: 22116824
[TBL] [Abstract][Full Text] [Related]
26. Altered T cell subpopulations and serum anti-TYRP2 and tyrosinase antibodies in the acute and chronic phase of alopecia areata in the C3H/HeJ mouse model.
Hashimoto K; Yamada Y; Fujikawa M; Sekiguchi K; Uratsuji H; Mori S; Watanabe H; Matsumoto T
J Dermatol Sci; 2021 Oct; 104(1):21-29. PubMed ID: 34511266
[TBL] [Abstract][Full Text] [Related]
27. Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts.
McElwee KJ; Boggess D; King LE; Sundberg JP
J Invest Dermatol; 1998 Nov; 111(5):797-803. PubMed ID: 9804341
[TBL] [Abstract][Full Text] [Related]
28. Alopecia areata: a review of disease pathogenesis.
Rajabi F; Drake LA; Senna MM; Rezaei N
Br J Dermatol; 2018 Nov; 179(5):1033-1048. PubMed ID: 29791718
[TBL] [Abstract][Full Text] [Related]
29. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
[TBL] [Abstract][Full Text] [Related]
30. Selective Expansion of Tregs Using the IL-2 Cytokine Antibody Complex Does Not Reverse Established Alopecia Areata in C3H/HeJ Mice.
Lee E; Kim M; Lee YJ
Front Immunol; 2022; 13():874778. PubMed ID: 35799786
[TBL] [Abstract][Full Text] [Related]
31. Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus).
Freyschmidt-Paul P; Ziegler A; McElwee KJ; Happle R; Kissling S; Sundberg JP; Hoffmann R
Eur J Dermatol; 2001; 11(5):405-9. PubMed ID: 11525945
[TBL] [Abstract][Full Text] [Related]
32. Hair follicle-derived mesenchymal stem cells decrease alopecia areata mouse hair loss and reduce inflammation around the hair follicle.
Deng W; Zhang Y; Wang W; Song A; Mukama O; Huang J; Han X; Deng S; Lin Z; Habimana JDD; Huang R; Peng K; Ni B; Zhang S; Yan X; Li J; Wu LP; Li Z
Stem Cell Res Ther; 2021 Oct; 12(1):548. PubMed ID: 34674748
[TBL] [Abstract][Full Text] [Related]
33. CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata.
Dai Z; Xing L; Cerise J; Wang EH; Jabbari A; de Jong A; Petukhova L; Christiano AM; Clynes R
J Immunol; 2016 Aug; 197(4):1089-99. PubMed ID: 27412416
[TBL] [Abstract][Full Text] [Related]
34. Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata.
Zöller M; McElwee KJ; Engel P; Hoffmann R
J Invest Dermatol; 2002 Jun; 118(6):983-92. PubMed ID: 12060392
[TBL] [Abstract][Full Text] [Related]
35. CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase.
Ito T; Hashizume H; Shimauchi T; Funakoshi A; Ito N; Fukamizu H; Takigawa M; Tokura Y
J Dermatol Sci; 2013 Feb; 69(2):140-7. PubMed ID: 23312578
[TBL] [Abstract][Full Text] [Related]
36. A cross-sectional study of the histopathology and immunology of alopecia areata: Unearthing the role of the Janus kinase-signal transducer and activator of transcription pathway.
Bansal A; Relhan V; Garg VK; Saran RK
Indian J Dermatol Venereol Leprol; 2019; 85(5):455-461. PubMed ID: 31031313
[TBL] [Abstract][Full Text] [Related]
37. Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells.
McElwee KJ; Hoffmann R; Freyschmidt-Paul P; Wenzel E; Kissling S; Sundberg JP; Zöller M
J Invest Dermatol; 2002 Dec; 119(6):1426-33. PubMed ID: 12485450
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast cell-based therapy prevents induction of alopecia areata in an experimental model.
Jalili RB; Kilani RT; Li Y; Khosravi-Maharlooie M; Nabai L; Wang EHC; McElwee KJ; Ghahary A
Cell Transplant; 2018 Jun; 27(6):994-1004. PubMed ID: 29871523
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of platelet-rich plasma on hair regrowth and lesional T-cell cytokine expression in alopecia areata: A randomized observer-blinded, placebo-controlled, split-head pilot study.
Gupta V; Parihar AS; Sharma VK; Jain S; Singh V; Khanna N
J Am Acad Dermatol; 2021 May; 84(5):1321-1328. PubMed ID: 33359595
[TBL] [Abstract][Full Text] [Related]
40. Amygdalin ameliorates alopecia areata on C3H/HeJ mice by inhibiting inflammation through JAK2/STAT3 pathway.
He X; Liu J; Gong Y; Lu W; Sha X; Cao C; Li Y; Wang J
J Ethnopharmacol; 2024 Sep; 331():118317. PubMed ID: 38723918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
